Description

Alecnib 150mg Capsule (Alectinib) Uses, Dosage, Side Effects & Availability in Pakistan

Alecnib 150mg Capsule (Alectinib) is an oral targeted cancer medicine containing alectinib. It belongs to a group of medicines called kinase inhibitors and is used for certain patients with ALK-positive non-small cell lung cancer (NSCLC). Alectinib works by blocking abnormal ALK signaling that can contribute to the growth and spread of cancer cells.

Because alectinib is a prescription oncology medicine, it should be used only under the supervision of an oncologist after appropriate testing confirms that the cancer is ALK-positive.

What Is Alecnib 150mg Capsule?

Alecnib 150mg Capsule contains alectinib, a targeted therapy used in the treatment of ALK-positive NSCLC. The standard alectinib capsule strength is 150mg. The official Alecensa product information describes 150mg hard capsules containing alectinib hydrochloride equivalent to 150mg of alectinib.

Unlike traditional chemotherapy, alectinib specifically targets a molecular abnormality known as anaplastic lymphoma kinase (ALK). Treatment selection requires an appropriate validated or approved test to confirm ALK-positive disease.

Alecnib 150mg Uses

Alecnib (alectinib) is used for certain adults with ALK-positive non-small cell lung cancer.

Adjuvant Treatment After Lung Cancer Surgery

Alectinib may be used as adjuvant treatment after complete surgical removal of the tumor in adults with ALK-positive NSCLC. Current U.S. prescribing information includes tumors that are 4 cm or larger or node-positive, as detected by an FDA-approved test.

The UK product information also describes adjuvant treatment for certain adults with completely resected Stage IB to IIIA ALK-positive NSCLC under its applicable staging criteria.

Advanced or Metastatic NSCLC

Alectinib is also used for adults with ALK-positive advanced or metastatic NSCLC. It may be used as a first-line treatment and is also indicated for patients with advanced ALK-positive NSCLC who were previously treated with crizotinib under the applicable product indication.

Before treatment, the ALK status should be confirmed through an appropriate diagnostic test.

How Does Alectinib Work?

ALK is a protein involved in signaling pathways that control cell growth and survival. In some lung cancers, changes involving the ALK gene can cause abnormal signaling that encourages cancer cells to grow.

Alectinib is a kinase inhibitor that targets ALK and helps block this abnormal signaling. By interfering with ALK activity, alectinib can help slow the growth or spread of ALK-positive cancer cells.

Alecnib 150mg Dosage

For adults receiving the standard regimen, the recommended dose of alectinib is 600mg twice daily with food. Since each capsule contains 150mg, this corresponds to four 150mg capsules per dose, taken twice daily.

For certain patients with severe hepatic impairment, the European product information recommends a lower starting dose of 450mg twice daily with food. Dose adjustments may also be necessary when serious adverse reactions occur.

The exact dose and duration of treatment must be decided by the treating oncologist. Patients should never change their dose without medical advice.

How to Take Alecnib 150mg Capsule

• Take Alecnib exactly as prescribed by your oncologist.
• Take the capsules with food.
• Take the prescribed doses at approximately the same times each day.
• Swallow the capsules whole with water.
• Do not change the dose or stop treatment without consulting your doctor.
• If you miss a planned dose, follow your oncologist’s instructions. The European product information states that a missed dose may be made up unless the next dose is due within 6 hours.

Treatment duration depends on whether alectinib is being used after surgery or for advanced disease. Adjuvant treatment may continue for up to 2 years unless the disease recurs or unacceptable toxicity develops, while treatment for advanced disease generally continues until disease progression or unacceptable toxicity.

Alecnib 150mg Side Effects

Like other cancer medicines, alectinib can cause side effects. Commonly reported effects may include:

• Tiredness or fatigue
• Muscle or joint pain
• Constipation
• Swelling or edema
• Anemia
• Changes in liver function tests
• Increased blood creatinine
• Weight gain
• Rash or other skin-related effects

The severity of side effects varies between patients. Regular medical monitoring can help identify problems early.

Serious Side Effects and Warnings

Liver Problems

Alectinib can cause hepatotoxicity, including increases in liver enzymes and, in some cases, serious liver injury. The current U.S. prescribing information recommends monitoring liver laboratory tests every two weeks during the first three months, followed by monthly monitoring and additional testing when clinically indicated.

Interstitial Lung Disease or Pneumonitis

Alectinib can cause serious lung inflammation known as interstitial lung disease or pneumonitis. Patients should promptly report new or worsening respiratory symptoms such as shortness of breath, cough or breathing difficulty.

Muscle Problems

Alectinib may cause elevations in creatine phosphokinase (CPK) and muscle-related problems. Unusual or severe muscle pain, weakness or dark-colored urine should be discussed with a healthcare professional.

Kidney Problems

Renal impairment can occur during treatment. Patients with significant changes in kidney function may require treatment interruption, dose adjustment or discontinuation depending on the clinical situation.

Alecnib 150mg Capsule Drug Interactions

Before starting alectinib, tell your doctor about all prescription medicines, over-the-counter products, vitamins and herbal supplements you take.

Some medicines can affect how alectinib is processed in the body and may increase or decrease its effects. Your healthcare professional may need to review your current medicines and adjust treatment accordingly.

Do not start a new medicine or supplement without discussing it with your doctor or pharmacist.

Alecnib 150mg Capsule During Pregnancy and Breastfeeding

Alectinib may cause fetal harm. Women who can become pregnant should discuss effective contraception with their healthcare professional during treatment and for the recommended period after the final dose.

Patients who are pregnant, planning pregnancy or breastfeeding should inform their doctor before starting alectinib. Breastfeeding is generally not recommended during treatment because of the potential risk to the infant.

Storage of Alecnib 150mg Capsule

Store Alecnib according to the storage instructions provided on the product packaging. The current U.S. Alecensa label states that the capsules should not be stored above 30°C and should remain in the original container to protect them from light and moisture.

Keep the medicine away from children and avoid storing it in areas exposed to excessive heat or moisture.

Alecnib 150mg Price in Pakistan

The price and availability of Alecnib 150mg Capsule (Alectinib) in Pakistan may vary depending on supplier, availability, import costs and market conditions.

For the latest Alecnib 150mg price and availability in Pakistan, customers can contact Impo Medic directly. The latest price and stock status should be confirmed before placing an order.

Alecnib 150mg Availability in Pakistan

The availability of Alecnib 150mg Capsule in Pakistan may vary depending on supplier availability, import conditions and market supply.

For current Alecnib 150mg availability in Pakistan, customers can contact Impo Medic for product-related information and availability. As a prescription oncology medicine, alectinib should only be used according to a qualified healthcare professional’s treatment plan.

Why Choose Impo Medic?

At Impo Medic, our goal is to provide access to specialized medicines along with clear and useful product information.

• Information about medicine strength and active ingredients
• Assistance with product availability
• Convenient online ordering support
• Focus on specialized and oncology medicines
• Customer support for product-related queries

Patients should confirm the required medicine, strength and treatment plan with their healthcare professional before ordering.

FAQs About Alecnib 150mg Capsule (Alectinib)

1. What is Alecnib 150mg Capsule used for?

Alecnib contains alectinib and is used for certain adults with ALK-positive non-small cell lung cancer, including specific cases following surgery and advanced or metastatic disease.

2. What is the usual dose of alectinib?

The standard adult dose is 600mg twice daily with food, which equals four 150mg capsules per dose. The dose may need adjustment in certain medical situations.

3. Should Alecnib be taken with food?

Yes. The recommended alectinib dose should be taken with food.

4. Is Alecnib a chemotherapy medicine?

Alectinib is a targeted cancer therapy and kinase inhibitor. It works by targeting ALK signaling rather than acting as traditional cytotoxic chemotherapy.

5. What are common Alecnib side effects?

Common side effects may include fatigue, muscle or joint pain, constipation, swelling, anemia and changes in liver or kidney laboratory results.

6. Does Alecnib require an ALK test?

Yes. Treatment selection requires confirmation that the NSCLC is ALK-positive using an appropriate diagnostic test.

7. Can I stop Alecnib if I feel better?

No. Do not stop alectinib without speaking with your oncologist. The duration of treatment depends on the type and stage of cancer and the patient’s response and tolerability.

8. Can Alecnib be taken without a prescription?

Alectinib is a prescription oncology medicine and should be taken only under the supervision of a qualified healthcare professional.

Medical Disclaimer

This article is intended for general educational purposes only and does not replace advice from an oncologist, doctor or pharmacist. Alecnib (alectinib) should only be used according to a healthcare professional’s prescription and treatment plan. Do not change the dose, stop treatment or combine medicines without medical advice.

Authoritative reference: The current official U.S. prescribing information for alectinib is available through.